Outcome of multimodality treatment for 188 cases of type B3 thymoma

Journal of Thoracic Oncology

Volumn 8, Issue 10, 2013, Pages 1329-1334

  Gao, Lanting ^a   Wang, Changlu ^a   Fang, Wentao ^b   Zhang, Jie ^b   Lv, Changxing ^a   Fu, Shen ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI CHEST HOSPITAL   (China)

^c SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Postoperative; Radiotherapy; Thymectomy; Thymoma; Type B3

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; FLUOROURACIL; IFOSFAMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MASAOKA STAGING; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MYASTHENIA GRAVIS; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THORACOTOMY; THYMECTOMY; THYMOMA; TREATMENT OUTCOME; TUMOR CLASSIFICATION; TUMOR RECURRENCE; TUMOR VOLUME; TYPE B3 THYMOMA; VERY ELDERLY; VIDEO ASSISTED THORACOSCOPIC SURGERY; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYMECTOMY; THYMOMA; THYMUS NEOPLASMS; YOUNG ADULT;

EID: 84892406620     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31829ceb50     Document Type: Article

References (30)

1. de Jong WK, Blaauwgeers JLG, Schaapveld M, et, al.Thymic epithelial tumours:a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer 2008; 44:123-130.
2. Engel P, Marx A, Müller-Hermelink HK. Thymic tumours in Denmark. A retrospective study of 213 cases from 1970-1993. Pathol Res Pract 1999; 195:565-570.
3. Dadmanesh F, Sekihara T, Rosai J. Histologic typing of thymoma according to the new World Health Organization classification. Chest Surg Clin N Am 2001; 11:407-420.
4. Travis William D, Brambilla E, Müller-Hermelink HK, et al. Pathology and genetics of tumors of the lung, pleura, thymus and heart. Tumors of the Thymus (World Health Organization Classification of Tumors) 2004:146-147.
5. Marchevsky AM, Gupta R, McKenna RJ, et al. Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer 2008;112:2780-2788.
6. Rena O, Papalia E, Maggi G, et al. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer 2005;50:59-66.
7. Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 2002;94:624-632.
8. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymoma with special reference to their clinical stages. Cancer 1981;48:2485-2492.
9. James Huang, Frank C, Detterbeck, et al. Standard outcome measure for thymic malignancies. J Thorac Oncol 2011;6:1691-1697.
10. Marchevsky AM, Gupta R, Casadio C, et al. World Health Organization classification of thymomas provides significant prognostic information for selected stage III patients: evidence from an international thymoma study group. Hum Pathol 2010;41:1413-1421.
11. Ruffini E, Van Raemdonck D, Detterbeck F, Rocco G, Thomas P, Venuta F; European Society of Thoracic Surgeons Thymic Questionnaire Working Group. Management of thymic tumors: a survey of current practice among members of the European Society of Thoracic Surgeons. J Thorac Oncol 2011;6:614-623.
12. Kim DJ, Yang WI, Choi SS, Kim KD, Chung KY. Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: a clinicopathologic study of 108 patients and literature review. Chest 2005;127:755-761.
13. Asamura H, Nakagawa K, Matsuno Y, Suzuki K, Watanabe S, Tsuchiya R. Thymoma needs a new staging system. Interact Cardiovasc Thorac Surg 2004;3:163-167.
14. Wright CD, Wain JC, Wong DR, et al. Predictors of recurrence in thymic tumors: importance of invasion. J Thorac Cardiovasc Surg 2005;130:1413-1421.
15. Masaoka A. Staging system of thymoma. J Thorac Oncol 2010;5(10 Suppl 4):S304-S312.
16. Riely GJ, Huang J. Induction therapy for locally advanced thymoma. J Thorac Oncol 2010;5(10 Suppl 4):S323-S326.
17. Aydiner A, Toker A, Sen F, et al. Association of clinical and pathological variables with survival in thymoma. Med Oncol 2012;29:2221-2228.
18. Yu L, Zhang XJ, Ma S, Jing Y, Li F, Krasna MJ. Different characteristics of thymomas with and without myasthenia gravis. Ann Surg Oncol 2012;19:94-98.
19. Bulkley GB, Bass KN, Stephenson GR, et al. Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis. Ann Surg 1997;226:324-34; discussion 334.
20. Okumura M, Miyoshi S, Takeuchi Y, et al. Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg 1999;117:605-613.
21. Davenport E, Malthaner RA. The role of surgery in the management of thymoma: a systematic review. Ann Thorac Surg 2008;86:673-684.
22. Patel S, Macdonald OK, Nagda S, Bittner N, Suntharalingam M. Evaluation of the role of radiation therapy in the management of malignant thymoma. Int J Radiat Oncol Biol Phys 2012;82:1797-1801.
23. Curran WJ Jr, Kornstein MJ, Brooks JJ, Turrisi AT 3rd. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 1988;6:1722-1727.
24. Monden Y, Nakahara K, Iioka S, et al. Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg 1985;39:165-169.
25. Chang JH, Kim HJ, Wu HG, Kim JH, Kim YT. Postoperative radiotherapy for completely resected stage II or III thymoma. J Thorac Oncol 2011;6:1282-1286.
26. Regnard JF, Magdeleinat P, Dromer C, et al. Prognostic factors and longterm results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996;112:376-384.
27. Korst RJ, Kansler AL, Christos PJ, Mandal S. Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg 2009;87:1641-1647.
28. Mangi AA, Wain JC, Donahue DM, Grillo HC, Mathisen DJ, Wright CD. Adjuvant radiation of stage III thymoma: is it necessary? Ann Thorac Surg 2005;79:1834-1839.
29. Sugie C, Shibamoto Y, Ikeya-Hashizume C, et al. Invasive thymoma: postoperative mediastinal irradiation, and low-dose entire hemithorax irradiation in patients with pleural dissemination. J Thorac Oncol 2008;3:75-81.
30. Uematsu M, Yoshida H, Kondo M, et al. Entire hemithorax irradiation following complete resection in patients with stage II-III invasive thymoma. Int J Radiat Oncol Biol Phys 1996;35:357-360.